Literature DB >> 18061457

A comparative study of treatment for brain edema: magnesium sulphate versus dexamethasone sodium phosphate.

Omer Faruk Turkoglu1, Hakan Eroglu, Ozerk Okutan, M Kagan Tun, Ebru Bodur, Mustafa F Sargon, Levent Oner, Etem Beskonakli.   

Abstract

Treatments for brain edema are important and one of the major options is corticosteroids. Cell membrane stabilization and prevention of formation of free radicals are the main mechanisms of action of steroids in edema treatment. As an alternative therapeutic agent, magnesium sulphate has been used for its neuroprotective effect in various injury models. In our animal model of brain injury, cold has been used in Sprague-Dawley rats. After brain injury, magnesium sulphate (600 mg/kg) or dexamethasone sodium phosphate (0.2 mg/kg) were administered to experimental groups. The degree of brain edema and lipid peroxidation was evaluated using the wet-dry weight method, the determination of malondialdehyde (MDA) levels and an ultrastructural grading system. Magnesium sulphate treatment was found to be the most effective choice due to the absence of side effects and comparable efficacy to corticosteroids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18061457     DOI: 10.1016/j.jocn.2007.03.005

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  3 in total

1.  Role of autophagy in early brain injury after experimental subarachnoid hemorrhage.

Authors:  Zhong Wang; Xiao-Yong Shi; Jia Yin; Gang Zuo; Jian Zhang; Gang Chen
Journal:  J Mol Neurosci       Date:  2011-07-05       Impact factor: 3.444

Review 2.  Magnesium sulfate for the treatment of eclampsia: a brief review.

Authors:  Anna G Euser; Marilyn J Cipolla
Journal:  Stroke       Date:  2009-02-10       Impact factor: 7.914

Review 3.  Emerging treatments for traumatic brain injury.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Expert Opin Emerg Drugs       Date:  2009-03       Impact factor: 4.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.